BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32335175)

  • 1. Reliability and usefulness of a rapid IgM-IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report.
    Spicuzza L; Montineri A; Manuele R; Crimi C; Pistorio MP; Campisi R; Vancheri C; Crimi N
    J Infect; 2020 Aug; 81(2):e53-e54. PubMed ID: 32335175
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
    Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
    Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans.
    Martinaud C; Hejl C; Igert A; Bigaillon C; Bonnet C; Mérens A; Wolf A; Foissaud V; Leparc-Goffart I
    J Clin Virol; 2020 Sep; 130():104571. PubMed ID: 32750664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of serum IgM and IgG for COVID-19 diagnosis.
    Zhong L; Chuan J; Gong B; Shuai P; Zhou Y; Zhang Y; Jiang Z; Zhang D; Liu X; Ma S; Huang Y; Lin H; Wang Q; Huang L; Jiang D; Hao F; Tang J; Zheng C; Yu H; Wang Z; Jiang Q; Zeng T; Luo M; Zeng F; Zeng F; Liu J; Tian J; Xu Y; Long T; Xu K; Yang X; Liu Y; Shi Y; Jiang L; Yang Z
    Sci China Life Sci; 2020 May; 63(5):777-780. PubMed ID: 32270436
    [No Abstract]   [Full Text] [Related]  

  • 8. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
    Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.
    Gambino CM; Lo Sasso B; Colomba C; Giglio RV; Agnello L; Bivona G; Ciaccio M
    Biochem Med (Zagreb); 2020 Oct; 30(3):030901. PubMed ID: 33071558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
    Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
    J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA.
    Hu X; Zhang R; An T; Li Q; Situ B; Ou Z; Wu C; Yang B; Tian P; Hu Y; Ping B; Wang Q; Zheng L
    Clin Chim Acta; 2020 Oct; 509():288-292. PubMed ID: 32569631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological characteristics of COVID-19 patients.
    Zhou M; Zhong J; Bi L; Shang P; Xing Y; Wang B; He J; Xu Y; Luo T; Ma M; Li Q
    Infect Dis (Lond); 2020 Oct; 52(10):749-750. PubMed ID: 32603629
    [No Abstract]   [Full Text] [Related]  

  • 14. Value and Validity of Coronavirus Antibody Testing.
    Mahajan A; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S381-S390. PubMed ID: 32942795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood.
    Wang Z; Zheng Z; Hu H; Zhou Q; Liu W; Li X; Liu Z; Wang Y; Ma Y
    Lab Chip; 2020 Nov; 20(22):4255-4261. PubMed ID: 33064114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to SARS-CoV-2 in patients with COVID-19.
    Long QX; Liu BZ; Deng HJ; Wu GC; Deng K; Chen YK; Liao P; Qiu JF; Lin Y; Cai XF; Wang DQ; Hu Y; Ren JH; Tang N; Xu YY; Yu LH; Mo Z; Gong F; Zhang XL; Tian WG; Hu L; Zhang XX; Xiang JL; Du HX; Liu HW; Lang CH; Luo XH; Wu SB; Cui XP; Zhou Z; Zhu MM; Wang J; Xue CJ; Li XF; Wang L; Li ZJ; Wang K; Niu CC; Yang QJ; Tang XJ; Zhang Y; Liu XM; Li JJ; Zhang DC; Zhang F; Liu P; Yuan J; Li Q; Hu JL; Chen J; Huang AL
    Nat Med; 2020 Jun; 26(6):845-848. PubMed ID: 32350462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of point-of-care IgM and IgG test in critically ill patients with SARS-Cov-2.
    Nguyen LS; Laghlam D; De Gonfreville E; Pène F; Rozenberg F; Mira JP
    Crit Care; 2020 Sep; 24(1):573. PubMed ID: 32972451
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis.
    Liu W; Kou G; Dong Y; Zheng Y; Ding Y; Ni W; Wu W; Tang S; Xiong Z; Zhang Y; Liu L; Zheng S
    J Clin Virol; 2020 Sep; 130():104576. PubMed ID: 32763810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.